Literature DB >> 790940

Pneumonia in the neonate associated with group B streptococcal septicemia.

V G Hemming, D W McCloskey, H R Hill.   

Abstract

Fifteen newborns referred to the University of Utah Neonatal Intensive Care Unit (NICU) between 1971 and 1974 had septicemia and bronchopneumonia caused by streptococci of Lancefield group B. Eight of these infants could not be distinguished from others with idiopathic respiratory distress syndrome. All eight died and at autopsy were found to have bronchopneumonia. At autopsy, five of the ten subjects had bilateral pleural effusions. Eight of these early onset infections were caused by type III strains, three by type II strains, and four by Ia strains. The three survivors were infected by Ia organisms; two of these patients received antimicrobial therapy within one hour of birth and the other was treated at 20 hours of age. Among the 12 patients who died, six received no antibiotics and five were treated 12 or more hours after delivery. Earlier recognition may lead to more efficacious therapy of this most fulminant infection of the newborn.

Entities:  

Mesh:

Year:  1976        PMID: 790940     DOI: 10.1001/archpedi.1976.02120120065011

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  16 in total

1.  Role of antibody and complement in opsonization of group B streptococci.

Authors:  A O Shigeoka; R T Hall; V G Hemming; C D Allred; H R Hill
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441

2.  Group B streptococci inactivate complement component C5a by enzymic cleavage at the C-terminus.

Authors:  J F Bohnsack; K W Mollison; A M Buko; J C Ashworth; H R Hill
Journal:  Biochem J       Date:  1991-02-01       Impact factor: 3.857

3.  Role of C5a-ase in group B streptococcal resistance to opsonophagocytic killing.

Authors:  S Takahashi; Y Nagano; N Nagano; O Hayashi; F Taguchi; Y Okuwaki
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

Review 4.  Common bacterial infections in infancy and childhood. 1. Respiratory infections.

Authors:  H C Spratt; G A Ahronheim; M I Marks
Journal:  Drugs       Date:  1978-08       Impact factor: 9.546

5.  Strain specificity of opsonins for group B streptococci types II and III.

Authors:  A O Shigeoka; R T Hall; H R Hill
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

Review 6.  Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens.

Authors:  Gunnar Lindahl; Margaretha Stålhammar-Carlemalm; Thomas Areschoug
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

7.  Phylogenetic lineage and pilus protein Spb1/SAN1518 affect opsonin-independent phagocytosis and intracellular survival of Group B Streptococcus.

Authors:  Debasish Chattopadhyay; Alison J Carey; Elise Caliot; Richard I Webb; James R Layton; Yan Wang; John F Bohnsack; Elisabeth E Adderson; Glen C Ulett
Journal:  Microbes Infect       Date:  2011-01-14       Impact factor: 2.700

8.  Group B streptococci (GBS) injure lung endothelium in vitro: GBS invasion and GBS-induced eicosanoid production is greater with microvascular than with pulmonary artery cells.

Authors:  R L Gibson; C Soderland; W R Henderson; E Y Chi; C E Rubens
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

9.  Restricted ability of group B streptococcal C5a-ase to inactivate C5a prepared from different animal species.

Authors:  J F Bohnsack; J K Chang; H R Hill
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

10.  Similarity between the group B and A streptococcal C5a peptidase genes.

Authors:  P P Cleary; J Handley; A N Suvorov; A Podbielski; P Ferrieri
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.